Cardioprotective Effect of Glycyrrhizin on Myocardial Remodeling in Diabetic Rats.
Cardioprotective Effect of Glycyrrhizin on Myocardial Remodeling in Diabetic Rats.
复制标题
DOI:
10.3390/biom11040569
复制
发表时间:
2021-04-13
期刊:
影响因子:
5.5
通讯作者:
Chattopadhyay M
中科院分区:
文献类型:
--
作者:
Thakur V;Alcoreza N;Delgado M;Joddar B;Chattopadhyay M
Myocardial fibrosis is one of the major complications of long-term diabetes. Hyperglycemia induced cardiomyocyte atrophy is a frequent pathophysiological indicator of diabetic heart. The objective of this study was to investigate the cardioprotective effect of glycyrrhizin (GLC) on myocardial damage in diabetic rats and assess the anti-inflammatory and anti-fibrotic effect of GLC. Our study demonstrates that hyperglycemia can elevate cardiac atrophy in diabetic animals. Type 2 diabetic fatty and the lean control rats were evaluated for cardiac damage and inflammation at 8–12 weeks after the development of diabetes. Western blot and immunohistochemical studies revealed that gap junction protein connexin-43 (CX43), cardiac injury marker troponin I, cardiac muscle specific voltage gated sodium channel NaV1.5 were significantly altered in the diabetic heart. Furthermore, oxidative stress mediator receptor for advanced glycation end-products (RAGE), as well as inflammatory mediator phospho-p38 MAPK and chemokine receptor CXCR4 were increased in the diabetic heart whereas the expression of nuclear factor erythroid-2-related factor 2 (Nrf2), the antioxidant proteins that protect against oxidative damage was reduced. We also observed an increase in the expression of the pleiotropic cytokine, transforming growth factor beta (TGF-β) in the diabetic heart. GLC treatment exhibited a decrease in the expression of phospho-p38 MAPK, RAGE, NaV1.5 and TGF-β and it also altered the expression of CX43, CXCR4, Nrf2 and troponin I. These observations suggest that GLC possesses cardioprotective effects in diabetic cardiac atrophy and that these effects could be mediated through activation of Nrf2 and inhibition of CXCR4/SDF1 as well as TGF-β/p38MAPK signaling pathway.
登录
查看更多内容
DOI:
10.3109/08977194.2011.595714
发表时间:
2011-10
期刊:
Growth factors (Chur, Switzerland)
影响因子:
--
作者:
Biernacka A;Dobaczewski M;Frangogiannis NG
通讯作者:
Frangogiannis NG
影响因子:
3.7
作者:
Lancefield TF;Patel SK;Freeman M;Velkoska E;Wai B;Srivastava PM;Horrigan M;Farouque O;Burrell LM
通讯作者:
Burrell LM
影响因子:
4.3
作者:
Liang, Bo;Guo, Xiao-Ling;Feng, Zheng-Quan
通讯作者:
Feng, Zheng-Quan
影响因子:
2.7
作者:
Cai, Xiangna;Wang, Xin;Chen, Shuying
通讯作者:
Chen, Shuying
影响因子:
2.5
作者:
Alonzo M;Delgado M;Cleetus C;Kumar SA;Thakur V;Chattopadhyay M;Joddar B
通讯作者:
Joddar B